PiVOT promotes PH as clinical research center
LOPEZ-LED PiVOT, the Philippines’ leading local contract research organization (CRO), celebrated its fifth anniversary by gathering in one venue in Manila key players shaping the future of clinical research in the country.
The gathering, dubbed PINNACLE 2024 and held recently at The Fifth at Rockwell Makati, offered a unique platform for top principal investigators, representatives from regulatory bodies and other leading figures to network and discuss the future of the clinical research landscape.
CROs provide outsourced and contractual support, mainly in the form of research services, to companies in the pharmaceutical, biotechnology and medical device industries. CRO services, which include studies and clinical trials for new drugs, help reduce costs for companies developing these new medications.
PiVOT acting general manager Ella Mae Ortega welcomed guests and shared PiVOT’s journey from its operational startup in 2019 with 10 employees to its status today as the largest Philippine CRO with over a hundred total manpower complement.
PiVOT completed 16 clinical trials, which involved roughly 40,000 participants. PiVOT president Joaquin Quintos IV urged stakeholders to seize the opportunity for the Philippines so it would become a major player in the global clinical research landscape.
Quintos underscored the need for collaboration within the Philippine clinical research sector. He compared the sector to the business process outsourcing industry, whose success highlights the importance of a unified front to attract global investment.